Anti-ICAM-1 antibody-modified nanostructured lipid carriers: a pulmonary vascular endothelium-targeted device for acute lung injury therapy

BACKGROUND: Acute lung injury (ALI) is a life-threatening clinical syndrome without effective treatment. Targeting delivery of glucocorticoid to lung shows potential efficacy for ALI based on their anti-inflammatory and anti-fibrotic properties, breaking through their clinical application limitation...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Shujuan, Chen, Li, Wang, Guokang, Xu, Lexing, Hou, Shanshan, Chen, Ziwei, Xu, Xiaoling, Wang, Xiaojuan, Liu, Fuhe, Du, Yong-Zhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6311082/
https://www.ncbi.nlm.nih.gov/pubmed/30594254
http://dx.doi.org/10.1186/s12951-018-0431-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6311082/
https://www.ncbi.nlm.nih.gov/pubmed/30594254
http://dx.doi.org/10.1186/s12951-018-0431-5

Ejemplares similares